• Date Range Restriction in Systematic Reviews: Navigating the Why, How, and When

    Date Range Restriction in Systematic Reviews: Navigating the Why, How, and When

    Systematic literature reviews (SLRs) play a pivotal role in evidence synthesis and informing healthcare decisions. One critical aspect of conducting an SLR is establishing a date range for the inclusion of studies. This temporal parameter, while seemingly straightforward, demands careful consideration. The decision to impose a date range restriction can significantly impact the comprehensiveness and reliability of the review.[1]

    The imposition of date range restrictions in SLRs serves several critical purposes. Firstly, it ensures the inclusion of the most recent and relevant evidence, acknowledging the dynamic nature of the healthcare landscape characterized by continuous advancements in research and technology. By setting a cutoff date, reviewers aim to focus on contemporary studies that accurately reflect the current state of knowledge and practice. Secondly, the application of date range restrictions is instrumental in managing the considerable workload associated with the SLR process. Given the vast volume of literature that the SLRs often entail, narrowing the focus to a specific timeframe becomes imperative. This strategic restriction not only streamlines the SLR process but also ensures that it remains feasible within the constraints of time and resources, enabling a comprehensive overview of the relevant literature. Additionally, date range restrictions play a crucial role in preventing the inclusion of outdated information. In healthcare, interventions, guidelines, and treatments undergo continuous refinement. Excluding older studies through a well-defined date range restriction becomes a deliberate choice aimed at eliminating information that may no longer be applicable or reflective of current best practices. This careful curation is essential for maintaining the relevance of SLR and its applicability to contemporary healthcare settings.[2]

    Effectively implementing date range restrictions in SLRs involves a thoughtful approach. Firstly, it is essential to clearly define the rationale behind the decision before setting a date range. Whether the goal is to capture the latest evidence, manage workload, or ensure relevance, a well-articulated rationale helps justify the chosen temporal parameters. Furthermore, the nature of the research question should be a guiding factor in establishing the date range. Different questions may require different temporal perspectives; some may necessitate a focus on recent developments, while others benefit from a historical context. Aligning the date range with the research question enhances the precision and relevance of the SLR, ensuring that the chosen timeframe aligns with the objectives of the study.[2]

    Transparency is of paramount importance in SLRs. Authors should explicitly report the chosen date range in the methods section, accompanied by a clear explanation of the rationale behind the decision. This transparency is crucial for aiding readers and reviewers in assessing the validity and applicability of the findings of the SLR, and in establishing trust in the methodology employed. In addition to transparency, the robustness of the SLR can be enhanced by conducting sensitivity analyses to assess the impact of the date range restriction. Comparing the results with and without restriction provides insights into the potential influence of the chosen temporal parameters on the overall findings of the SLR. This analytical approach adds an extra layer of validation, demonstrating the thoroughness and reliability of the methodology of the SLR.[3]

    Imposing an inaccurate date cutoff in SLRs can have significant consequences. Very important among them is the potential loss of valuable information, particularly when a crucial comparator or pivotal study was published just before the specified date. Excluding such pertinent studies may result in an incomplete representation of available evidence, compromising the robustness and validity of the conclusions drawn by the SLR. Furthermore, date range restrictions can introduce bias into comparisons between interventions or treatments. If comparators are subject to different date ranges, the SLR may inadvertently favor interventions with more recent evidence, leading to skewed conclusions. This bias has the potential to impact the overall assessment of interventions and treatments, hampering the reliability of the findings of the SLR. Moreover, the imposition of a rigid date range can result in the neglect of historical context. Certain research questions benefit from an exploration of older studies that provide valuable insights into the evolution of interventions or treatments. An inflexible date range may overlook these insights, impacting the depth and richness of the narrative. Therefore, the consequences of an inaccurate cutoff extend beyond mere omission, influencing the integrity and comprehensiveness of the findings of the SLR.[4]

    The consequences extend to meta-analyses, where date range restrictions can have unintended effects. If the chosen date range disrupts the balance of studies across interventions, the synthesis of data may be skewed. This imbalance can influence the overall effect size and draw potentially misleading conclusions from the meta-analysis, undermining the reliability of the quantitative synthesis. In assessing studies just outside the specified date range, their potential impact on the overall review’s robustness should be carefully reviewed. If the exclusion of these critical studies proves to compromise the completeness and reliability of the SLR significantly, it may prompt a re-evaluation of the initially set date range.[2]

    In rapidly evolving fields, where emerging trends or interventions may lack a substantial body of recent literature, strict date range restrictions can pose limitations on the SLR’s ability to capture the full spectrum of available evidence. Reviewers must be aware of this challenge and contemplate alternative approaches. One such approach could involve conducting separate analyses for emerging and established interventions, recognizing the unique dynamics and evidence landscapes within these categories. To further mitigate the risk of overlooking important evidence, systematic reviewers should consider the incorporation of continuous surveillance mechanisms and periodic updates. This proactive strategy enables the ongoing integration of new evidence without compromising the overall structure and methodology of the review. By staying attuned to emerging studies, reviewers can enhance the timeliness and relevance of their SLRs, ensuring that they remain reflective of the dynamic nature of the field.[4]

    In conclusion, the imposition of date range restrictions in SLRs is a crucial methodological decision that requires careful consideration. While there are valid reasons for setting temporal boundaries, the potential consequences of an inaccurate cutoff cannot be understated. The loss of valuable information, biased comparisons, and unintended impacts on meta-analyses underscore the importance of a nuanced approach to date range selection. Systematic reviewers must strive for transparency, align the chosen date range with the research question, and remain open to reconsideration when critical studies are just outside the specified timeframe. By navigating the complexities of date range restrictions with diligence and flexibility, SLRs can fulfill their role as reliable sources of evidence for informed decision-making in healthcare.

    Become A Certified HEOR Professional – Enrol yourself here!

    References

    1. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group*. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine. 2009 Aug 18;151(4):264-9.
    2. Helbach J, Pieper D, Mathes T, Rombey T, Zeeb H, Allers K, Hoffmann F. Restrictions and their reporting in systematic reviews of effectiveness: an observational study. BMC Medical Research Methodology. 2022 Dec;22(1):1-0.
    3. Aali G, Shokraneh F. No limitations to language, date, publication type, and publication status in search step of systematic reviews. Journal of Clinical Epidemiology. 2021 May 1;133:165-7.
    4. Sterne JA, Egger M, Smith GD. Investigating and dealing with publication and other biases in meta-analysis. Bmj. 2001 Jul 14;323(7304):101-5.
  • Including Conference Abstracts for Evidence Synthesis Through Systematic Reviews

    Including Conference Abstracts for Evidence Synthesis Through Systematic Reviews
    Including Conference Abstracts for Evidence Synthesis Through Systematic Reviews

    Systematic literature reviews (SLRs) serve as the gold standard for evidence synthesis, informing healthcare decisions. However, a pertinent question arises in the methodology of these reviews: should conference abstracts be included in the search for relevant studies? This query prompts a comprehensive examination of both the advantages and disadvantages, with the ultimate decision based on the specific goals of the SLR.[1]

    Conference abstracts, often preceding full publications, provide timely access to critical information. This timeliness is especially vital in rapidly evolving fields, ensuring that SLRs stay current and offer an up-to-date perspective on the existing evidence landscape. Further, considering that not all conference abstracts are published in peer-reviewed journals, excluding abstracts translates to the exclusion of valuable data, compromising the comprehensiveness of the SLR.[1]

    It is well known that SLRs that rely solely on published studies carry a risk of publication bias which can distort the overall treatment effect estimate. Publication bias arises out of the selective publication of studies with positive results. Including conference abstracts acts as a countermeasure to this, offering a more balanced representation of study outcomes, regardless of their direction. This inclusion contributes to a more nuanced understanding of the effectiveness of the intervention.[1]

    Excluding conference abstracts that report early trial findings particularly randomized controlled trials (RCTs) from the evidence synthesis process introduces ethical concerns as well. Patient participation is grounded in the expectation that their contribution will contribute to scientific knowledge. The non-fulfillment of this commitment is viewed as an ethical problem, emphasizing the importance of including conference abstracts to honor the contributions of study participants. This ethical dimension adds a layer of responsibility to systematic reviewers, urging them to consider the broader implications of excluding conference abstracts.[1]

    Conference abstracts frequently present findings with direct policy implications. Including them in SLRs ensures that policy decisions are informed by the latest and potentially impactful research. This alignment of SLR processes with real-world applications enhances the relevance and applicability of the synthesized evidence, making it a valuable resource for policymakers and healthcare practitioners. The advantages of including conference abstracts extend beyond the content they provide, contributing to a more dynamic and adaptive SLR process.[1]

    However, the process of identifying relevant conferences, extracting abstracts, and sifting through extensive collections can be resource-intensive. Despite advancements like the inclusion of conference abstracts in searchable databases such as EMBASE, challenges persist. Abstracts, characterized by brevity, may lack essential information for systematic reviewers to comprehensively assess study design, methods, bias risk, outcomes, and results. The concise nature of abstracts poses a challenge for reviewers seeking a thorough understanding of the included studies. Additionally, the non-standard format of conference abstracts presents an additional layer of complexity, further complicating the extraction and evaluation process.[3]

    Moreover, abstracts often lack peer review, and their preliminary nature may result in unreliable information. Discrepancies between abstracts and subsequent full publications, particularly in critical aspects such as methods and results, raise questions about the dependability of abstracts. While meta-epidemiologic studies have shown only minor differences in results between meta-analyses with and without conference abstracts, the inclusion of “gray” literature, including conference abstracts, may lead to shifts in significance levels or, in some cases, no substantial change.[3,4]

    In conclusion, the decision to include conference abstracts in SLRs should be carefully considered. The advantages, including timeliness, addressing publication bias, ethical considerations, and informing policy decisions, underscore the potential benefits. However, challenges related to resource intensity, information adequacy, and reliability necessitate a nuanced approach. By adopting a flexible and evidence-driven strategy, systematic reviewers can harness the benefits of including conference abstracts without compromising the integrity of their synthesis efforts.

    Become A Certified HEOR Professional – Enrol yourself here!

    References

    1. Hackenbroich S, Kranke P, Meybohm P, Weibel S. Include or not to include conference abstracts in systematic reviews? Lessons learned from a large Cochrane network meta-analysis including 585 trials. Systematic Reviews. 2022 Dec;11(1):1-0.
    2. Murad H, Smith J, Singh G, Deber R. Methodological and reporting quality of conference abstracts: a systematic review. J Clin Epidemiol. 2013;66(7):705-15.
    3. Cohen AM, Glazner JE, Roeder K, Sandvik L. Does inclusion of published abstracts of randomized controlled trials in systematic reviews affect risk ratio estimates? J Clin Epidemiol. 2014;67(7):796-802.
    4. Egger M, Davey SG, Davey A. Bias in the selection of conference abstracts for presentation. Lancet. 1997;349(9055):1069-70.